# OnCo record ose-immunotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ose-immunotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ose-immunotherapeutics" ;
  schema:name "OSE Immunotherapeutics"@en ;
  schema:description "OSE Immunotherapeutics develops immune treatments for cancer and inflammatory disease. Its lead cancer product is an off-the-shelf vaccine for lung cancer patients whose immunotherapy has stopped working, now in a late-stage trial."@en ;
  schema:url <https://onco.cc/companies/ose-immunotherapeutics/>, <https://www.ose-immuno.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.ose-immuno.com>, <https://www.ose-immuno.com/en/press-releases/>, <https://www.ose-immuno.com/wp-content/uploads/2026/05/OSE-PR_EN_260528_IRIS-Financing-vdef.pdf> ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/ose2101/> ;
  onco:trials <https://onco.cc/trials/nct05751798/> .